Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1961
|
| gptkbp:ATCCode |
gptkb:N06AF03
|
| gptkbp:brand |
gptkb:phenelzine
|
| gptkbp:chemicalFormula |
C8H12N2
|
| gptkbp:contraindication |
gptkb:tricyclic_antidepressants
gptkb:SSRIs tyramine-rich foods |
| gptkbp:drugClass |
monoamine oxidase inhibitor
|
| gptkbp:eliminationHalfLife |
11.6 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nardil
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
weight gain drowsiness sexual dysfunction |
| gptkbp:usedFor |
gptkb:depression
gptkb:panic_disorder gptkb:social_anxiety_disorder treatment-resistant depression atypical depression |
| gptkbp:bfsParent |
gptkb:Phenelzine
gptkb:phenelzine |
| gptkbp:bfsLayer |
7
|